Back to first-pass browser

First-pass extracted concept

AMPK signaling

Candidate: concept label1 source documents3 linked claims
Jump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

AMPK

Evidence Snippets

signaling pathways, such as AMPK, HIF-1, and c-Myc, play key roles in tumor metabolic regulation
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1mechanistic modelsupports2026Source 1DOIPubMed

Metabolic and signaling mechanisms interact synergistically to allow hepatocellular carcinoma cells to survive and proliferate despite targeted therapies, resulting in drug resistance.

Quoted textsource-backed
These mechanisms interact synergistically, allowing HCC cells to endure and proliferate despite targeted therapies, ultimately resulting in drug resistance.
Claim 2mechanistic rolesupports2026Source 1DOIPubMed

AMPK, HIF-1, and c-Myc signaling pathways play key roles in tumor metabolic regulation relevant to hepatocellular carcinoma drug resistance.

Quoted textsource-backed
Moreover, signaling pathways, such as AMPK, HIF-1, and c-Myc, play key roles in tumor metabolic regulation, influencing energy balance, gene expression under hypoxia, and metabolic pathway control.
Claim 3therapeutic rationalesupports2026Source 1DOIPubMed

Understanding metabolic and signaling regulation of aerobic glycolysis may reveal causes of drug resistance in hepatocellular carcinoma and provide new therapeutic targets and strategies.

Quoted textsource-backed
Therefore, a deeper understanding of these metabolic and signaling regulatory mechanisms will help reveal the fundamental causes of drug resistance in HCC and provide new targets and directions for future therapeutic strategies.